Is Roche Coming Back?

Is Roche Coming Back?

Just when you think you have seen it all the wacky world of diabetes proves you wrong. Over the last two trading sessions shares of Tandem are up almost 30% with more than 12% of shares outstanding trading over that time span. (Shares are up again in early trading this morning.) This move comes after earnings which were less than stellular and an outlook that was so so at best.

Just to review earnings were released Wednesday. Given the results it was understandable that in after-hours trading shares were down 10%. Yet the following day shares closed UP 11 . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.